These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15869463

  • 1. Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.
    Mars WM, Jo M, Gonias SL.
    Biochem J; 2005 Aug 15; 390(Pt 1):311-5. PubMed ID: 15869463
    [Abstract] [Full Text] [Related]

  • 2. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
    Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK.
    Cancer Res; 1996 Jun 15; 56(12):2837-43. PubMed ID: 8665523
    [Abstract] [Full Text] [Related]

  • 3. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
    Paciucci R, Vilá MR, Adell T, Díaz VM, Torà M, Nakamura T, Real FX.
    Am J Pathol; 1998 Jul 15; 153(1):201-12. PubMed ID: 9665481
    [Abstract] [Full Text] [Related]

  • 4. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF.
    Cancer Res; 2000 Jan 15; 60(2):342-9. PubMed ID: 10667586
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES, Menicucci G, McGuire PG, Das A.
    Invest Ophthalmol Vis Sci; 2007 Apr 15; 48(4):1793-800. PubMed ID: 17389513
    [Abstract] [Full Text] [Related]

  • 6. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G, D'Alessio S, Pucci M, Cerletti M, Del Rosso M.
    Biol Chem; 2002 Jan 15; 383(1):127-36. PubMed ID: 11928807
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.
    Wojta J, Nakamura T, Fabry A, Hufnagl P, Beckmann R, McGrath K, Binder BR.
    Blood; 1994 Jul 01; 84(1):151-7. PubMed ID: 7517205
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
    Christensen L, Wiborg Simonsen AC, Heegaard CW, Moestrup SK, Andersen JA, Andreasen PA.
    Int J Cancer; 1996 May 16; 66(4):441-52. PubMed ID: 8635858
    [Abstract] [Full Text] [Related]

  • 9. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.
    Mars WM, Zarnegar R, Michalopoulos GK.
    Am J Pathol; 1993 Sep 16; 143(3):949-58. PubMed ID: 8362987
    [Abstract] [Full Text] [Related]

  • 10. A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.
    Nieves EC, Manchanda N.
    J Biol Chem; 2010 Apr 23; 285(17):12595-603. PubMed ID: 20177061
    [Abstract] [Full Text] [Related]

  • 11. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
    Hall CL, Tsan R, Mugnai G, Mazar A, Radinsky R, Pettaway CA.
    Prostate; 2004 May 01; 59(2):167-76. PubMed ID: 15042617
    [Abstract] [Full Text] [Related]

  • 12. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.
    Int J Oncol; 2005 Jul 01; 27(1):223-35. PubMed ID: 15942664
    [Abstract] [Full Text] [Related]

  • 13. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM.
    Mod Pathol; 2003 Jan 01; 16(1):14-21. PubMed ID: 12527708
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
    Chung HW, Wen Y, Ahn JJ, Moon HS, Polan ML.
    J Clin Endocrinol Metab; 2001 Mar 01; 86(3):1332-40. PubMed ID: 11238529
    [Abstract] [Full Text] [Related]

  • 15. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME, Rijken DC, Groeneveld E, van Berkel TJ, Kuiper J.
    Thromb Haemost; 1995 Aug 01; 74(2):722-9. PubMed ID: 8585013
    [Abstract] [Full Text] [Related]

  • 16. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
    Roldán-Olarte M, García DC, Jiménez-Díaz M, Valdecantos PA, Miceli DC.
    Anim Reprod Sci; 2012 Dec 01; 136(1-2):90-9. PubMed ID: 23103014
    [Abstract] [Full Text] [Related]

  • 18. The urokinase receptor and cell migration.
    Blasi F.
    Semin Thromb Hemost; 1996 Dec 01; 22(6):513-6. PubMed ID: 9122717
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells.
    Pepper MS, Matsumoto K, Nakamura T, Orci L, Montesano R.
    J Biol Chem; 1992 Oct 05; 267(28):20493-6. PubMed ID: 1328201
    [Abstract] [Full Text] [Related]

  • 20. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.
    Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM.
    EMBO J; 1992 Dec 05; 11(13):4825-33. PubMed ID: 1334458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.